Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
DFTX
Definium Therapeutics, Inc.
NASDAQ · Medicinal Chemicals & Botanical Products
Last close
$38.06
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Medicinal Chemicals & Botanical Products
Market cap
$5.11B
RECENT INSIDER TRADES
2026-09-29
· Barrow Robert
(Chief Executive Officer)
· SELL
2026-09-29
· Roberts Brandi
(Chief Financial Officer)
· SELL
2026-09-29
· Sullivan Mark
(Chief Legal Officer)
· SELL
2026-09-29
· Wiley Matthew T.
(Chief Commercial Officer)
· SELL
2026-09-29
· Karlin Daniel
(Chief Medical Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
364
Shares held
118,027,262
Value
$5.18B
Percent of shares outstanding
87.84%
As of quarter end
2026-06-30
RECENT NEWS
Definium Therapeutics CMO Daniel Karlin sells $396,894 in stock
Definium Therapeutics CEO Robert Barrow sells $1.15 million in shares
Definium Therapeutics CLO Mark Sullivan sells $513,845 in shares
Definium Therapeutics CCO Matthew Wiley sells $113,257 in common shares
Canaccord raises Definium Therapeutics price target on trial results
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS